Sarah Khan

81PUBLICATIONS
265CO-AUTHORS
Medical virologyPharmacogenomicsCancer geneticsMetabolic medicineGastroenterology and hepatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (81)

|Jun 23, 2026
The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease.

|Jun 07, 2026
Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial.

|May 04, 2026
Fibroblast Growth Factor 21: Mechanisms, Therapeutic Potential, and Clinical Translation in Metabolic Dysfunction.

|Apr 28, 2026
A reasonably likely surrogate endpoint for metabolic dysfunction-associated steatohepatitis.

|Apr 27, 2026
Multi-threshold analysis of the ELF Test versus histology for prognostication of disease progression and regression in MASH.

|Apr 02, 2026
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial.

Sebastian M Meyhöfer, Bertrand Cariou, Cintia Cercato

Pageof 14

Frequent Collaborators

20 joint publications

Rohit Loomba

11 joint publications

Quentin M Anstee

8 joint publications

Brent Neuschwander-Tetri

7 joint publications

Vlad Ratziu